CJRCF(CJRCF)
CJRCF
No analyst ratings available
No analyst price targets available for CJRCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $24.16B | $25.37B | $25.59B |
| Low | $23.32B | $22.81B | $23.83B |
| High | $24.85B | $28.00B | $27.31B |
| EBITDA Avg | $4.18B | $4.39B | $4.43B |
| Low | $4.03B | $3.95B | $4.12B |
| High | $4.30B | $4.84B | $4.72B |
| EBIT Avg | $1.89B | $1.98B | $2.00B |
| Low | $1.82B | $1.78B | $1.86B |
| High | $1.94B | $2.19B | $2.13B |
| Net Income Avg | $404M | $884M | $1.04B |
| Low | $368M | $805M | $944M |
| High | $439M | $961M | $1.13B |
| EPS Avg | $0.06 | $0.13 | $0.15 |
| Low | $0.05 | $0.12 | $0.14 |
| High | $0.06 | $0.14 | $0.16 |
| Analysts (Rev / EPS) | 8 / 1 | 11 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $4.12B | $4.12B | $4.11B | $4.11B | $4.10B | $4.10B |
| Low | $4.12B | $4.12B | $4.11B | $4.11B | $4.10B | $4.10B |
| High | $4.12B | $4.12B | $4.11B | $4.11B | $4.10B | $4.10B |
| EBITDA Avg | $713M | $712M | $711M | $710M | $710M | $709M |
| Low | $713M | $712M | $711M | $710M | $710M | $709M |
| High | $713M | $712M | $711M | $710M | $710M | $709M |
| EBIT Avg | $322M | $322M | $321M | $321M | $321M | $320M |
| Low | $322M | $322M | $321M | $321M | $321M | $320M |
| High | $322M | $322M | $321M | $321M | $321M | $320M |
| Net Income Avg | $486M | $324M | $162M | $243M | $486M | $243M |
| Low | $486M | $324M | $162M | $243M | $486M | $243M |
| High | $486M | $324M | $162M | $243M | $486M | $243M |
| EPS Avg | $0.07 | $0.05 | $0.02 | $0.03 | $0.07 | $0.03 |
| Low | $0.07 | $0.05 | $0.02 | $0.03 | $0.07 | $0.03 |
| High | $0.07 | $0.05 | $0.02 | $0.03 | $0.07 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |